NANOTAG
Live / Registered — Registered (as of 17 Oct 2023)
What this means for you
Registered since 17 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97423500
- Registration number
- 7192326
- Mark type
- Word mark
- Filed
- 23 May 2022
- Published for opposition
- 01 Aug 2023
- Registered
- 17 Oct 2023
- Attorney of record
- Ryan D. Artis
Goods and services
- Class 001 — Chemicals: Chemical reagents for scientific or industrial purposes; Chemical reagents for scientific or industrial purposes, namely, for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis; diagnostic or analytical kits containing chemical reagents for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of infectious diseases, solid and hematological cancers, neurodegenerative diseases and autoimmune diseases; Diagnostic preparations for medical or veterinary purposes; drugs or vaccines for the treatment of infectious diseases, solid and hematological cancers, neurodegenerative diseases and autoimmune diseases
Owner
- NanoTag Biotechnologies GmbH, Goettingen, DE
- NanoTag Biotechnologies GmbH, Goettingen, DE
- NanoTag Biotechnologies GmbH, Goettingen, DE
Prosecution history
- 17 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Aug 2023 — PUBLISHED FOR OPPOSITION
- 12 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 23 Jun 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 17 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Mar 2023 — NON-FINAL ACTION E-MAILED
- 11 Mar 2023 — NON-FINAL ACTION WRITTEN
- 11 Mar 2023 — ASSIGNED TO EXAMINER